- Published on
Medicine – Human Immunodeficiency Virus (HIV)
Human immunodeficiency virus (HIV) is an enveloped RNA retrovirus that primarily infects CD4+ T lymphocytes, leading to progressive immune dysfunction. Without effective antiretroviral therapy (ART), HIV infection may eventually progress to acquired immunodeficiency syndrome (AIDS).
HIV is an RNA retrovirus containing reverse transcriptase. Its progressive depletion of CD4+ T lymphocytes impairs cell-mediated immunity, increasing susceptibility to opportunistic infections and malignancies.
1. Virology of HIV
HIV belongs to the family Retroviridae and the genus Lentivirus.
Important Characteristics
- RNA retrovirus: HIV contains two copies of single-stranded, positive-sense RNA.
- Reverse transcriptase: Converts viral RNA into DNA.
- Integrase: Incorporates viral DNA into the host cell genome.
- Protease: Processes viral proteins during maturation of new virions.
- Envelope glycoproteins: gp120 mediates attachment, while gp41 facilitates fusion with the host cell membrane.
Illustration: Structure of HIV
2. HIV Replication Cycle
HIV replicates through a series of steps involving attachment, fusion, reverse transcription, integration, viral production, assembly and maturation.
Stages of HIV Replication
- Attachment: gp120 binds to CD4 and a coreceptor, usually CCR5 or CXCR4.
- Fusion: gp41 facilitates fusion of the viral envelope with the host cell membrane.
- Reverse transcription: Reverse transcriptase converts viral RNA into DNA.
- Integration: Integrase inserts viral DNA into the host genome.
- Replication: Host cell machinery produces viral RNA and proteins.
- Assembly and maturation: New virions bud from the cell and undergo protease-mediated maturation.
Illustration: HIV Replication Cycle
3. Types of HIV
There are two principal types of human immunodeficiency virus:
- HIV-1: Most prevalent worldwide.
- HIV-2: Predominantly associated with West Africa.
Comparison of HIV-1 and HIV-2
| Feature | HIV-1 | HIV-2 |
|---|---|---|
| Geographical distribution | Worldwide | Predominantly West Africa |
| Prevalence | Most common | Much less common |
| Transmissibility | Generally higher | Generally lower |
| Disease progression | Usually faster without treatment | Often slower |
| Viral load | Generally higher | Generally lower |
| NNRTI susceptibility | Many effective options | Intrinsic resistance |
4. Pathophysiology – Progressive CD4 Cell Depletion
HIV primarily targets immune cells expressing the CD4 receptor.
Main Target Cells
- CD4+ T-helper lymphocytes.
- Macrophages.
- Dendritic cells.
Progressive depletion and dysfunction of CD4+ T lymphocytes lead to impaired cell-mediated immunity.
This increases susceptibility to opportunistic infections and certain malignancies.
Illustration: Mechanism of HIV-Induced Immunodeficiency
The CD4 count provides an important measure of immune function, while HIV viral load measures circulating viral RNA and helps assess the response to ART.
5. Modes of HIV Transmission
HIV is transmitted through exposure to infectious body fluids, including blood, semen, vaginal and rectal fluids, and breast milk.
A. Sexual Transmission
HIV may be transmitted through sexual exposure to infectious genital or rectal fluids.
- Receptive or insertive anal intercourse.
- Vaginal intercourse.
- Oral sex, although the risk is extremely low.
Risk depends on viral load, mucosal injury, coexisting sexually transmitted infections and protective measures.
People with HIV who maintain an undetectable viral load on effective ART do not sexually transmit HIV. This principle is known as Undetectable = Untransmittable (U=U).
B. Sharing Needles and Injection Equipment
HIV may be transmitted through sharing contaminated needles, syringes or other injecting equipment.
This is particularly relevant among people who inject drugs.
C. Blood and Blood Products
HIV may be transmitted through:
- Transfusion of contaminated blood or blood products.
- Organ or tissue transplantation from an infected donor.
- Occupational needlestick injuries involving infected blood.
Modern blood-donor screening has made transfusion-associated HIV transmission extremely rare in settings with effective screening systems.
D. Mother-to-Child Transmission
HIV may be transmitted from mother to child during:
- Pregnancy (intrauterine transmission).
- Labour and delivery.
- Breastfeeding.
Effective maternal ART, appropriate infant prophylaxis and recommended perinatal care can dramatically reduce transmission risk.
Breastfeeding recommendations depend on local guidelines, access to safe feeding alternatives and sustained maternal viral suppression.
Illustration: Major Routes of HIV Transmission
6. Comparison of HIV Transmission Routes
| Route | Mechanism | Important Point |
|---|---|---|
| Sexual intercourse | Exposure to infectious genital or rectal fluids | U=U prevents sexual transmission |
| Oral sex | Oral mucosal exposure to infectious fluids | Extremely low risk |
| Shared needles | Direct blood exposure | Avoid sharing injecting equipment |
| Blood products | Transfusion of contaminated blood | Screening greatly reduces risk |
| Occupational needlestick | Percutaneous exposure to infected blood | Urgent PEP assessment |
| Pregnancy and delivery | Maternal-to-child transmission | Maternal ART markedly reduces risk |
| Breastfeeding | Exposure through breast milk | Risk reduction depends on ART and feeding guidance |
7. HIV Is Not Transmitted Through Casual Contact
HIV is not transmitted through:
- Handshakes, hugging or ordinary social contact.
- Sharing toilets, plates or cutlery.
- Coughing or sneezing.
- Mosquito bites.
- Sweat, tears or saliva in ordinary social contact.
- Sharing swimming pools.
HIV transmission requires exposure to infectious body fluids through a route capable of establishing infection.
8. Prevention of HIV Infection
- Consistent and correct condom use.
- Pre-exposure prophylaxis (PrEP) for eligible HIV-negative individuals.
- Post-exposure prophylaxis (PEP), started as soon as possible and no later than 72 hours after a significant exposure.
- Use of sterile needles and injecting equipment.
- Screening of blood and blood products.
- HIV testing and early initiation of ART.
- Effective maternal ART and perinatal prevention strategies.
People with HIV who maintain sustained viral suppression on effective ART do not sexually transmit HIV. This is an important principle of modern HIV prevention.
9. High-Yield Examination Summary
| Feature | Key Fact |
|---|---|
| Virus family | Retroviridae |
| Genus | Lentivirus |
| Genome | Two copies of single-stranded RNA |
| Key enzyme | Reverse transcriptase |
| Other enzymes | Integrase and protease |
| Main target cell | CD4+ T lymphocyte |
| HIV-1 | Most prevalent worldwide |
| HIV-2 | Predominantly associated with West Africa |
| Main immunological effect | Progressive CD4+ T-cell depletion |
| Transmission | Sexual, bloodborne and mother-to-child |
| Oral sex | Extremely low transmission risk |
| U=U | Sustained viral suppression prevents sexual transmission |
10. Key Examination Pearls
- HIV is an enveloped RNA retrovirus containing reverse transcriptase.
- HIV-1 is responsible for most HIV infections worldwide.
- HIV-2 is more prevalent in West Africa and generally progresses more slowly.
- HIV-2 is intrinsically resistant to NNRTIs.
- Progressive depletion of CD4+ T lymphocytes causes immune dysfunction.
- HIV is transmitted through sexual exposure, contaminated blood or injecting equipment, and mother-to-child transmission.
- Oral sex carries a very low risk; the historical 5% figure is not a reliable transmission estimate.
- Effective ART preserves immune function and prevents sexual transmission when viral suppression is sustained.
HIV is an RNA retrovirus that uses reverse transcriptase to produce viral DNA. It progressively depletes CD4+ T lymphocytes, causing immunodeficiency. HIV-1 is prevalent worldwide, whereas HIV-2 is particularly associated with West Africa.
This article is intended for medical education and examination revision. HIV prevention, diagnosis and treatment should follow current clinical guidelines. Following a significant potential exposure, urgent assessment for PEP is recommended within 72 hours.
Kembara Xtra – Medicine Revision Notes